Biotech company develops innovative treatments for retinal diseases to reduce treatment burden and improve patient outcomes.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Kalaris is a clinical-stage biotechnology company focusing on developing innovative treatments for retinal diseases. Their lead product, TH103, is designed to address unmet needs in retinal care by potentially reducing treatment burdens and improving patient outcomes.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Theia Therapeutics Management Team
Theia Therapeutics Valuations & Financials
View real-time NPM data on Theia Therapeutics stock including daily Theia Therapeutics stock price estimates, valuation history, and historical share price information. Access Theia Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Theia Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Theia Therapeutics? Get in touch to learn more.
Similar Companies
like Theia Therapeutics
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
ArsenalBio
Healthcare & Life Sciences
Develops programmable cell therapies for cancer patients.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Kallyope
Healthcare & Life Sciences
Biotech company developing therapies targeting gut-brain axis interactions to treat metabolic and neurological diseases.
Clio
Healthcare & Life Sciences
Comprehensive legal practice management software designed to help law firms manage their operations more efficiently.
Array Behavioral Care
Healthcare & Life Sciences
Provider of telepsychiatry and telebehavioral health services.
Sollis Health
Healthcare & Life Sciences
Delivers personalized primary care and clinical services with a focus on patient‑centered care delivery.
Colossal Laboratories & Biosciences
Healthcare & Life Sciences
Pioneering biotech that reconstructs genomes for species restoration and ecosystem revitalization with innovative genetic engineering.
Avalyn Pharma
Healthcare & Life Sciences
Develops inhaled therapies for rare respiratory diseases like idiopathic pulmonary fibrosis and interstitial lung diseases.
FAQ
We have answers
Theia Therapeutics stock does not trade on public stock exchanges. Theia Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Theia Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Theia Therapeutics Stock does not trade on public stock exchanges. In order to sell Theia Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Theia Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Theia Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Theia Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Theia Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Theia Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Theia Therapeutics is a private company and has not had an IPO. There is currently no Theia Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Theia Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
